10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Innovative Therapies and Drug Discovery
The future of treating infectious diseases lies in innovative therapies and drug discovery, where new scientific advancements are reshaping treatment landscapes. As drug resistance continues to rise and new pathogens emerge, the need for alternative therapeutic options has never been more critical. Researchers in the realm of innovative therapies and drug discovery are exploring a variety of methods, from developing small molecules that target bacterial resistance mechanisms to designing vaccines that can preemptively neutralize infections. Breakthroughs in biotechnology and molecular biology are making it possible to rapidly identify potential drug candidates and accelerate clinical trials. This progress holds the promise of more effective, efficient, and accessible treatments to address infectious diseases on a global scale.
Ranjan Ramasamy
IDFISH Technology, United States
Saurabh Chattopadhyay
University of Kentucky College of Medicine, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Michele Mishto
Francis Crick Institute, United Kingdom
Seki Masafumi
Saitama Medical University International Medical Center, Japan
Stephanie Maltais
University of Montreal, Canada
Smriti Chaudhary
Imperial College Healthcare NHS Trust, United KingdomSubmit your abstract Today
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada